Purpose: To evaluate the visual and refractive results of microkeratome-assisted lamellar keratoplasty (LK) performed on keratoconus patients intolerant to spectacles and contact lenses.

Design: Prospective, noncomparative, interventional study.

Participants: A microkeratome-assisted LK procedure was performed on 50 eyes of 50 keratoconus patients. All patients were spectacle and contact lens intolerant.

Intervention: All patients included in this study underwent a standard surgical procedure involving removal of a lamella (9 mm in diameter cut with the 250-microm microkeratome head) from the recipient cornea by means of a hand-driven microkeratome and suturing of a donor lamella (0.5 mm smaller in diameter than the removed corneal lamella, cut with the 350-microm microkeratome head) obtained from a cornea mounted on an artificial anterior chamber. Each patient was examined preoperatively and at different postoperative times (1 and 6 months and 1, 2, 3, and 4 years).

Main Outcome Measures: Uncorrected visual acuity (UCVA), best spectacle-corrected visual acuity (BSCVA), 1-year best contact lens-corrected visual acuity (BCLCVA), refraction, and computerized analysis of corneal topography.

Results: After suture removal was completed, both UCVA and best-corrected visual acuity were significantly improved over properative values at all examination times. One year postoperatively, when follow-up was still available for all patients, UCVA was better than 20/200 in 8 of 50 (16%) patients and BSCVA was > or =20/40 in 44 of 50 (88%) patients, whereas BCLCVA was > or =20/40 in all 50 patients. Refractive astigmatism within 4 diopters was seen in 43 of 50 (86%) patients. Corneal topographic patterns were classified as regularly astigmatic in 39 of 50 (78%) patients. The 1-year values did not change substantially at later postoperative examination times. Complications included preparation of donor grafts of poor quality that needed to be discarded (8 cases [16%]), irregular astigmatism of various degrees (11 cases [22%]), high-degree astigmatism requiring secondary intervention (6 cases [12%]), epithelial interface ingrowth (1 case [2%]), and cataract formation (1 case [2%]).

Conclusions: Microkeratome-assisted LK can be performed on corneas with moderate to advanced keratoconus with a minimal corneal thickness of >380 microm. The procedure is relatively simple, may be standardized in most of its parts, and does not involve time-consuming maneuvers. All complications recorded did not threaten vision and were dealt with successfully. Our results indicate that microkeratome-assisted LK is as efficacious as conventional penetrating keratoplasty for the surgical treatment of keratoconus. However, the time necessary to achieve stable results is considerably shorter.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ophtha.2005.01.024DOI Listing

Publication Analysis

Top Keywords

visual acuity
16
patients
10
microkeratome-assisted lamellar
8
lamellar keratoplasty
8
keratoplasty surgical
8
surgical treatment
8
treatment keratoconus
8
keratoconus patients
8
microkeratome head
8
examination times
8

Similar Publications

Purpose This study evaluated the efficacy of oral melatonin therapy for visual acuity and retinal and choroidal structures in patients with chronic central serous chorioretinopathy (CSCR). Methods Fourteen patients with CSCR were included; eight received oral melatonin (3 mg nightly), and six formed the control group. Best-corrected visual acuity (BCVA), central macular thickness (CMT), central choroidal thickness (CCT), and choroidal vascularity index (CVI) were assessed at baseline and after one month.

View Article and Find Full Text PDF

Optic nerve disorders significantly contribute to visual impairment with irreversible visual deficits. Current treatments have limited efficacy in resolving chronic visual deficits, necessitating novel therapeutic strategies. Neurorehabilitation techniques, including repetitive transorbital alternating current stimulation (rtACS), have emerged as promising approaches to restore lost visual function through the ability to modulate brain activity.

View Article and Find Full Text PDF

Background: Age-related macular degeneration (AMD) is a prevalent cause of irreversible vision loss worldwide, particularly among the elderly population. Two forms of late AMD are described: neovascular AMD (nAMD), characterized by abnormal choroidal blood vessel growth, and atrophic (dry) AMD, involving retinal cell degeneration. Intravitreal anti-vascular endothelial growth factor (anti-VEGF) agents have transformed nAMD treatment, with Brolucizumab emerging as a promising therapy.

View Article and Find Full Text PDF

Purpose: Systemic sclerosis (SSc) affects blood vessels, internal organs, and skin. In ophthalmology, SSc impacts the choroid. The choroidal vascularity index (CVI) measures the vascular component of the choroid and may serve as a biomarker for the disease staging and prognosis.

View Article and Find Full Text PDF

Late presentation of Coats disease in a 12-year-old boy: a case report.

Pan Afr Med J

January 2025

Department of Ophthalmology, Faculty of Medicine Universitas Airlangga, Dr Soetomo Hospital, Surabaya, Indonesia.

Coats disease is a rare abnormality characterized with retinal telangiectasia and aneurysms with retinal exudation, most often seen in young males and usually affecting only one eye. A 12-year-old boy came in with a three-month history of vision loss and pain in his right eye, alongside progressively worsening blurred vision over the last year. His visual acuity was reduced to only light perception in the right eye, while his left eye maintained 5/5 vision.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!